Daniella Ballou-Aares, a member of IBEX Ltd's board, executed a series of common-stock sales totaling $162,809, according to a Form 4 filing with the Securities and Exchange Commission.
The filing details two transactions on March 13, 2025, when Ballou-Aares sold 5,843 shares at $24.2175 per share and 157 shares at $24.2114 per share. Later in the year, on December 2, 2025, she sold an additional 500 shares at $35.01 per share. Across these trades, the prices ranged from $24.2114 to $35.01 per share.
After completing the sales noted in the filing, Ballou-Aares directly owns 10,643 shares of IBEX Ltd.
Market context provided in the filing and subsequent market data show IBEX shares trading at $29.72, representing a decline of roughly 18% over the past six months. Independent analysis from InvestingPro, referenced in public materials about the company, characterizes the stock as appearing undervalued at current levels, citing a price-to-earnings ratio of 9.8. The same analysis highlights that management has been actively repurchasing shares - one of the 11+ InvestingPro Tips available for deeper review - and notes that a Pro Research Report covering IBEX is available alongside reports on more than 1,400 other U.S. equities.
Separately, IBEX disclosed strong financial performance in its second quarter of fiscal year 2026. The company reported revenue of $164.2 million, a 16.7% increase from the comparable period a year earlier. Adjusted earnings per share for the period were $0.87, a rise of 46% year over year. Those results exceeded analyst expectations, and the company’s shares rose during aftermarket trading following the release. Analysts continue to monitor IBEX's progress in light of these results.
The Form 4 filing documents precise transaction details and current holdings but does not provide the director's intentions behind the sales. The combination of insider selling, management repurchases, a recent pullback in the share price, and stronger-than-expected quarterly results presents a mixed data set for investors weighing IBEX's outlook.
Readers seeking deeper coverage of the stock and underlying metrics can consult the InvestingPro resources mentioned above, which include valuation metrics and additional tips for further analysis.